Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study by Dr Nick Scott, Ms Anna Palmer, Mr Tom Tidhar, Prof Mark Stoove, Dr Rachel Sacks-Davis, A/Prof Joseph S. Doyle, Dr Alisa Pedrana, Prof Alexander J. Thompson, Prof David P. Wilson, Prof Margaret Hellard

Get full text